Project feasibility report

PRE FEASIBILITY REPORT
For
PROPOSED EXPANSION OF BULK DRUGS AND BULK
DRUG INTERMEDIATES IN EXISTING
MANUFACTURING UNIT
of
M/s. SULESHVARI PHARMA
Plot No. 6012/1, GIDC, Ankleshwar – 393 002,
Dist. Bharuch, Gujarat, INDIA.
0
CONTENTS
Sr. No.
Description
Page No.
1.
Executive Summary
2
2.
Introduction of the Project/Background information
16
3.
Project Description
17
4.
Site Analysis
23
5.
Planning Brief
24
6.
Proposed Infrastructure
26
7.
Rehabilitation and resettlement (R & R) Plan
26
8.
Project Schedule & Cost Estimates
26
9.
Analysis of Proposal (Final Recommendations)
27
1
1.0
EXECUTIVE SUMMARY
1.1 Company Profile
M/s. Suleshvari Pharma engages in manufacturing and repacking of bulk drugs and bulk
drug intermediates at at Plot No. 6012/1, GIDC, Ankleshwar - 393 002, Dist: Bharuch,
Gujarat, INDIA.
Now, company is going for expansion of existing manufacturing and repacking unit by
addition of new products and solvent distillation unit (in-house or common group facility)
within existing premises.
1.2 Project Details
1.2.1 Products along with Production Capacity
Sr. Products
No.
(A)
1
Bulk drugs/Bulk Drugs Intermediates
Iso Amyl Acetate
Production Capacity
(MT/Month)
Existing
Additional
Total
2
3
4
5
6
7
Iso Amyl Propionate
Iso Amyl Butyrate
Phenyl Ethyl Acetate
Phenyl Ethyl Propionate
Methyl -3- Amino Crotonate
Phthalimido Amlodipine
1
1
1
1
1
1
1
Or
8
Diaminomethyleneamino (1-amino-1iminomethylene) thiomethyl thiozole
dihydrochloride [ITU]-50
9
--
1
123-92-2
----4
4
1
1
1
1
5
5
&
105-68-0
106-27-4
103-45-7
122-70-3
14205-39-1
88150-62-3
41
50
&
Or
9
N-Sulfomyl-3-chloropropionamide
hydrochloride[IF]-50
10
Famotidine
11
Poly Allaylamine Hydrochloride
12
Sevelamer Hydrochloride
9
Or
4
Or
9
Or
9
CAS No.
41
6
191
106649-95-0
50
&
10
&
200
&
76824-35-6
71550-12-4
152751-57-0
2
13
Sevelamer Carbonate
14
Fomepizole
15
Colsevelam hydrochloride
16
Glimepiride
17
Furosemide
18
Betahistine Dihydrochloride
19
Adapalene
20
Telmisartan
21
Tapentadol Hydrochloride
Or
9
Or
0.6
Or
7.5
Or
2.9
Or
9
Or
3.2
Or
1.5
Or
6.5
Or
8
Or
3.5
22 Colistimethate Sodium
Proposed
23 Rusvastatin Calcium
24 1-3 dichloro Acetone
25 Gunylthiourea
26 Rabeprazole Sodium
27 Carvediol
28 Celecoxib
29 Clopidogrel Bisulfate
30 Atoravastatin Calcium
31 Etoricoxib
32 Valsartan
33 Tranexamic Acid
34 Folic Acid
35 Zolpidic Acid
36 Pregabaline
Total (A)
Distillation(B)
(B)
37
38
REPACKING
Benzophenone (Repacking)
Para
Cresyl
Phenyl
(Repacking)
Acetate
9
0
845273-93-0
7554-65-6
182815-44-7
93479-97-1
54-31-9
5579-84-0
20
20
106685-40-9
144701-48-4
175591-09-0
8068-28-8
147098-20-2
534-07-6
2114-02-5
117976-90-6
72956-09-3
169590-42-5
120202-66-6
134523-03-8
202409-33-4
137862-53-4
1197-18-8
59-30-3
189005-44-5
148553-50-8
336
25
345
25
3.0
0.5
OR
3
39
Poly
Allaylamine
(Repacking)
Hydrochloride
13.5
OR
40
OR
41
42
Allaylamine (Repacking)
Allaylamine
Hydrochloride
(Repacking)
Micronization of Bulk Drugs/APIs
(Famotidine,
Amlodipine,
Glibenclamide,
Sevelamer
HCl,
Glimepride, Adapalene, ITU, IF,
Colsevelam
HCl,
Furosemide,
Telmisartan,
Betahistine
Dihydrochloride, Tapentadol HCl…etc)
Total (C)
Total (A+B+C)
13.5
100
113.5
100
461
113.5
483.5
13.5
-
13.5
22.5
1.3 Raw Material Requirement
Sr. No. Raw Material
1
2
3
4
Iso Amyl Acetate
Amyl alcohol
Catalyst
Toluene
Acetic acid
Iso Amyl Propionate
Amyl alcohol
Catalyst
Toluene
Propionic acid
Iso Amyl Butyrate
Amyl alcohol
Catalyst
Toluene
Butyric acid
Phenyl Ethyl Acetate
Toluene
Acetic Acid
Phenyl Ethyl Alcohol
PTSA
Quantity
(MT/Month)
0.70
0.05
0.60
0.55
0.70
0.05
0.60
0.55
0.60
0.05
0.60
0.60
1.00
0.65
1.25
0.06
4
5
6
7
8
9
10
Phenyl Ethyl Propionate
Toluene
Propionic Acid
Phenyl Ethyl Alcohol
PTSA
Methyl-3-Amino Crotonate
Methyl Aceto Acetate
Liq. Ammonia
Methanol
Phthalimido Amlodipine
Xylene
Phthalic Anhydride
Mono Ehanol Amine
Benzene
Sodium hydride
E4CAA
Acetic Acid
Methanol
Ortho Chloro Benzaldehyde : 129 Kg.
Morpholine
Methyl-3-Amino Crotonate : 294 Kg.
Mono Ethanol Amine
Diaminomethyleneamino
(1-amino-1iminomethylene)
thiomethyl
thiozole
dihydrochloride [ITU]
1,3 DCA
Guanyl Thiourea
Acetone
Catalyst
Thiourea
Acetic Acid
N-Sulfomyl-3-chloropropionamide
hydrochloride [IF]
Acrylonitrile
Hydrogen Peroxide
HCl (Gas)
Sulfamide
Acetone
Famotidine
ITU
IF
Methanol
1.00
0.75
1.15
0.06
5.62
4.50
1.50
7.50
1.50
0.625
8.25
0.415
0.81
1.73
2.925
0.645
0.08
1.47
0.625
0.435
0.413
3.100
0.004
0.261
0.261
1.303
0.008
1.495
0.500
0.400
1.150
0.965
5.710
5
11
12
13
14
15
16
NaOH
Water
Acetic Acid
Sevelamer Hydrochloride
Allylamine
2,2-Dimethyl-2,2-azopropane dihydrochloride
HCl
Epichlorhydrin
NaOH Flakes
Sevelamer Carbonate
SevelamerHCl
Caustic soda flakes
Carbon dioxide
Poly Allaylamine Hydrochloride
Allylamine
2,2-Dimethyl-2,2-azopropane dihydrochloride
HCl
Fomepizole
Propanaldehyde
Ethanol
Hexane
Phosphorus oxychloride
Hydrazine Hydrate
Potassium Carbonate
Carbon
Di isopropyl Ether
N,N-Dimethyl Formamide
Dichloro Methane
Colsevelam hydrochloride
Monoallylamine
2,2-dimethyl-2,2-azopropane dihydrochloride
Concentrated Hydrochloric acid
Methanol
Polyallylamine
Epichlorohydrin
n-Decylchloride
Trimethylammoniumhexylchloride
Sodium hydroxide
Glimepiride
3 Ethyl methyl Pyrroline
2 Phenyl ethyl isocyanate
Toluene
0.690
20.50
0.200
0.75
0.03
1.25
0.11
0.37
1.111
0.333
0.278
0.333
0.117
0.600
1.31
0.015
0.015
3.45
1.10
0.75
0.15
0.02
0.01
0.03
0.60
0.01
1.15
0.31
0.90
0.01
0.02
0.02
0.45
0.40
0.40
0.15
6
17
18
19
20
21
Chloro Sulfonic Acid
Ammonia Solution
EDC
Furosemide
Furfuryl Amine
Lasamide
Caustic Flake
IPA
Carbon
Acetic Acid
Betahistine Dihydrochloride
2- vinyl pyridine
Methylamine hydrochloride
Chloroform
Sodium hydroxide
Acetic Acid
IPA
IPA HCl(20%)
Adapalene
Adamentanol
Para Bromo Phenol
THF
Mg Turning
MDC
6-Bromo-2-methyl naphthoate
HCl
Telmisartan
4-Amino 3- Methylbenzoic acid
Conc. Sulphuric Acid
Liq. Ammonia
Methanol
MDC
TEA
Butryl Chloride
Sodium Bicarbonate
Sodium Sulphate
Hexane
Fuming Nitric Acid
Tapentadol Hydrochloride
3-methoxy propiophenone
IPA
Dimethyl Amine HCL
1.00
3.10
0.30
0.450
0.850
0.234
0.240
0.080
0.220
0.63
0.80
0.23
0.45
0.06
0.01
1.38
0.48
0.30
0.025
0.06
0.04
0.72
1.32
1.484
1.423
2.968
0.06
0.03
0.01
1.287
0.153
0.387
0.02
4.050
1.412
0.350
1.059
7
22
23
Paraformadehyde
Sodium Hydroxide
MDC
0.588
0.376
0.350
L (-) Dibenzoyl tartaric acid
THF
Mg Turning
Ethyl Bromide
Acetic Acid
Ammonium Solution
Ethyl Acetate
Trifluroacetic anhydride
Palladium
Acetone
HBr
IPA HCl
Colistimethate Sodium
Colistin Sulphate
Sodium Bicarbonate
Sodium Carbonate
Formaldehyde
Sodium Bisulfite
Acetic Acid
Solvent
Acetone
Methanol
Rusvastatin Calcium
4-Fluoro Benzaldehyde
4-Methyl-3-oxo-Pentatonic Acid Ethyl Ester
Potassium Hydroxide
Methyl Iodide
Methanol
5-Methyl Iso Thio Urea
2,3-Dichloro-5,6-Dicyano Benzoquinone
HMPA
MDC
Meta Chloro Peroxy Benzoic Acid
Methyl Amine
Ethanol
Methane Sulfonyl Chloride
1.412
0.080
0.171
0.588
0.118
0.506
0.230
0.882
0.070
0.260
1.765
0.882
1.33
0.67
0.33
1.33
3.06
0.16
0.80
2.00
3.00
0.52
0.66
0.24
0.60
5.50
0.35
0.85
1.00
8.00
0.11
0.10
2.50
0.35
8
24
25
26
Sodium Hydride (60%)
Di Methoxy Ethane
Hydrogen
DIBAL-H
Toluene
Methyl(3R)-3-(tert butyl dimethyl silyloxy)-5oxo-6-triphenyl phosphoranylidene hexanoate
Triethyl Amine
N,N-Dimethyl Formamide
Hydrogen Fluoride
THF
Ethyl Acetate
Diethyl Methoxy Borane
Sodium Borohydride
Calcium Chloride
1-3 dichloro Acetone
Epichlorohydrin
HCl (30%)
Sulfuric Acid (98%)
Sodium Dichromate
Gunylthiourea
Phosphorus Penta Sulphide
KOH
Dicyanadiamide
Sodium Hydro Sulphite
Rabeprazole Sodium
2,3-Lutidine
H2O2 (50%)
Nitric Acid
Acetic Acid
3-Methoxy 1-Propanol
NaOH
Toluene
DMSO
Acetic Anhydride
HCl
Thionyl Chloride
MDC
Sodium Sulphate
0.01
3.00
0.01
0.01
8.00
1.45
0.15
3.00
0.05
7.50
10.50
0.20
0.01
0.13
1.302
3.125
1.862
1.562
0.827
1.000
0.909
0.181
0.460
0.330
0.380
0.060
0.430
0.155
0.012
0.010
0.390
0.200
0.530
0.370
0.100
9
27
28
29
2-Mercaptobenzimidazole
Ammonium Hydroxide
Sodium Hypochlorite (8%)
Acetone
Sodium Hydro Sulphate
MMA
IPA
Activated Carbon
Carvediol
4-Hydroxy Carbazole
Epichlorohydrin
Hydrose
Methanol
Ethyl Acetate
Carbon
Hyflo
Monoethylene Glycol Dimethyl Ether
2-(2-Methoxy Phenoxy) Ethyl Amine
Acetone
Potassium Carbonate
Oxalic Acid
IPA
Sodium Sulphate
Ortho Phosphoric Acid
Celecoxib
4 SPH
Dione Deri
Toluene
Carbon
Clopidogrel Bisulfate
amino(2-chlorophenyl)acetic acid
methanol
Potassium salt
MDC
Liq. ammonia
Thiophene-2-Ethanol
p-toluene sulphonyl chloride
Toluene
Sodium hydroxide
Acetonitrile
Dipotassium phosphate
0.530
0.125
3.270
0.100
0.120
0.100
0.150
0.100
0.447
0.790
0.116
0.067
0.029
0.022
0.005
2.330
0.956
0.101
0.372
0.532
0.052
0.207
0.442
0.70
0.65
2.80
0.01
1.25
0.20
0.7
0.50
0.62
0.5
1.05
0.16
1.25
0.32
0.87
10
30
31
Ethyl acetate
HCL
P-Formaldehyde
MDC
Liq. Ammonia
Acetone
Tartaric acid
MDC
Sodium carbonate
Acetone
Activated carbon
Sulfuric acid
Atoravastatin Calcium
Ethyl-4-Cyano-3-hydroxy butanaote
THF
Diisopropyl amine
N-Butyl Lithium
Tert-Butyl acetate
HCl
Ethyl Acetate
NaCl
Methanol
DEMB (50 % Soln)
Sodium Borohydride
Acetic Acid
Dimethoxy Propane
Methane Sulphonic Acid
Sodium Bicarbonate
n-Hexane
Raney Nickel
Pivalic Acid
Toluene
Activated Carbon
Methyl Tert Butyl
Etoricoxib
Acetic Acid
Acetone
0.28
0.85
0.53
1.02
0.60
1.10
0.82
0.67
0.70
0.24
0.15
0.31
1.00
0.85
1.22
0.6
1.68
0.76
1.5
1.20
1.02
0.70
0.44
0.98
1.81
0.03
2.00
0.023
1.00
0.240
0.45
0.100
0.410
1.520
2.80
11
32
33
Ammonia Solution
CPT-Phosphate
D M Water
Hydroxylamine Hydrochloride
Hyflow
Isopropyl Alcohol
Ketosulfone
Methanol
Potassium Tertrabutoxide (KTB)
Sodium Acetate
Sodium Hydroxide
Toluene
THF
Trifluro Acetic Acid
Activated Carbon
Hexane
Valsartan
L-Valine
Methanol
Thionyl Chloride
Toluene
DCM
NaOH
NaCL
4-Bromo Methyl 2-Cyano biphenyl
Acetonitrile
Potassium Carbonate
Oxalic Acid
o-Xylene
Valeoryl Chloride
Sodium Bicarbonate
HCl
Tributyl Tin Chloride
Calcium Hydroxide
Ethyl Acetate
Diisopropyl ether
TBAB
Tranexamic Acid
4-aminomethyl benzoic
Acid
HCl
Ruthenium
5.80
1.520
26.00
0.115
0.177
10.00
0.574
10.00
0.664
0.297
2.153
55.000
23.00
0.465
0.022
0.250
1.44
0.23
6.90
0.38
2.41
0.65
0.29
2.17
1.00
1.49
1.00
1.16
1.24
0.28
0.65
5.55
0.42
0.35
7.17
0.14
1.060
0.440
0.300
12
34
35
36
Sodium hydroxide
Methanol
Folic Acid
PABGA
TAPS
TCA
SMBS
NaHCO3
HCl 30%
NaOH
Acetic Acid
Zolpidic Acid
Toluene
Methyl Phenacyl bromide
2- Amino-5-methyl pyridine
Triethyl amine
Oxalyl chloride
Methylene Dichloride
Potassium hydroxide
Acetic acid
Hydrazine hydrate
Methanol
Pregabaline
Sodium Hydroxide
4-CMH
Liquid Bromine
Activated carbon
Hyflo
Hydrochloric acid
IPA
0.252
2.000
1.00
0.90
0.64
0.36
1.20
6.00
0.22
0.32
0.128
1.000
0.611
0.531
0.700
1.000
1.340
1.651
0.431
1.000
1.90
1.37
1.23
0.07
0.02
2.46
7.06
1.4 Water Requirement, Waste Water Generation and Treatment
Total water requirement will be 50 KL/Day which will be met through GIDC water supply.
The wastewater generation will be 27.4 KL/Day. The Low COD effluent (22 KLD) will be sent
to proposed ETP consists of primary treatment facility and then after sent to CETP,
Ankleshwar & High COD/TDS stream (3 KL/Day) shall be sent to common MEE for further
treatment. Domestic Wastewater (2.4 KL/Day) will be disposed to soak pit/septic tank.
13
1.5 Air Pollution Source and Control Management
There will be emission from Steam Boiler and Process Vents. To control the emission from
process vents, adequate two stage scrubbers will be installed.
Sr.
No.
Source
Emission
of
Existing
1
Boiler
(Capacity: 0.6 TPH)
2
Process
Vent
(Reactor Vessel)
Stack/Vent
(meter)
Height Diameter
Fuel name &
Quantity use
Type of
Emission
APCE
SPM
SO2
NOx
Cl2
NH3
HCl
--
15
0.2
Natural Gas =
300 m3/Day
11
0.2
--
TOTAL AFTER PROPOSED EXPANSION
Flue Gas Emission
1
Boiler (Existing)
15
0.2
(Capacity: 0.6TPH)
Natural Gas =
300 m3/Day
SPM
SO2
NOx
SPM
SO2
NOx
SPM
SO2
NOx
Two Stage Water &
Caustic scrubber
--
Multicyclone
separator with bag
filter
Multicyclone
separator with bag
filter
2
Boiler (Proposed)
(Capacity: 1.0 TPH)
30
0.5
Agro waste = 3
MT/Day
3
Thermic
fluid
heater (Proposed)
(Capacity: 4 Lac K.
Cal/Hr.)
D. G.Set
30
0.5
Agro waste = 2
MT/Day
11
0.1
HSD
SPM
SO2
NOx
--
11
0.2
--
Two Stage Water &
Caustic scrubber
11
0.2
--
Cl2
NH3
HCl
HCl
SO2
4
Process Gas Emission
5
Process
Vent
(Reactor Vessel)
(Existing)
6
Process
Vent
(Reactor Vessel)
(Proposed)
Two Stage Water &
Caustic scrubber
14
1.6 Hazardous Waste
Sr. Hazardous/Solid
No. Waste
Category
Quantity
MT/Month
Existing
Total after
proposed
expansion
0.2
0.3
1
Used Oil
5.1
2
Organic Process
Waste
28.1
0.06
15
3
ETP Sludge
35.3
--
10
Discarded
Bags & Liners
Discarded
Containers
33.1
50
Nos./Month
10 Nos./
Month
500
Nos./Month
100
Nos./Month
5
Process Waste
28.1
--
25
6
Spent Carbon
28.2
--
2
7
Spent Catalyst
28.3
--
2
4
Mode Of Disposal
Collection,
Storage,
Transportation
and
reuse or sell to Register
Re-processors.
Collection,
Storage,
Transportation
and
disposal at CHWIF of
BEIL, Ankleshwar or
given
to
cement
industries
for
coprocessing.
Collection,
Storage,
Transportation
and
disposal at Common
TSDF
of
BEIL,
Ankleshwar
Collection,
Storage,
Transportation
and
reuse or sell to GPCB
Registered Vendor after
Decontamination.
Collection,
Storage,
Transportation
and
disposal at CHWIF of
BEIL, Ankleshwar or
given
to
cement
industries
for
coprocessing.
Collection,
Storage,
Transportation
and
disposal at CHWIF of
BEIL, Ankleshwar or
given
to
cement
industries
for
coprocessing.
Collection,
Storage,
Transportation and give
15
8
Dil. HCl
--
--
100
9
Inorganic Salt
--
--
15
to
generator
to
regenerate
Collection,
Storage,
Transportation and sell
to end user
Collection,
Storage,
Transportation
and
disposal at Common
TSDF
of
BEIL,
Ankleshwar
1.7 Green Belt
Total 2345 m2 land area is available at site; out of this area about 790 sq. meter (33 %) area
will be covered as greenbelt and other forms of greenery.
1.8 Power & Fuel Requirements
Power required from GEB is 100 KVA (Existing)
Power required from GEB will 250 KVA (Proposed)
1 D.G. Set = 150 KVA (Proposed) (For Emergency Only)
Fuel:
Natural Gas = 300 Sm3/Day(Existing)
Agro Waste/Briquettes = 5 MT/Day (Proposed)
HSD = 20 Liter/Hr (Proposed) (For Emergency Only)
2.0
INTRODUCTION OF THE PROJECT/BACKGROUND INFORMATION
2.1 Identification of the project and project proponent. In case of mining project, a copy
of mining lease/letter of intent should be given.
Identification of the project
Expansion of existing manufacturing and repacking unit by addition of new products and
solvent distillation unit (in-house or common group facility).
Identification of the project proponent
SR.
NAME
DESIGNATION
NO.
1 Mr. Ramesh Nanjibhai
Partner
Patel
2
Mr. Lalit Laxmichand
Gami
Partner
ADDRESS
206, Akash Ganga Co Operative
Society, GIDC, Ankleshwar.
Mob: +91 98284014578
408/14, Sardar Patel Society,
GIDC, Ankleshwar.
Mob: +91 9828406461
16
3
Mr. Kailash
Laxmichand Patel
Partner
4
Mr. Bharti Laxmichand
Patel
Partner
408/14, Sardar Patel Society,
GIDC, Ankleshwar.
Mob: +91 9924115437
408/14, Sardar Patel Society,
GIDC, Ankleshwar
Mob: +91-2646-226676
2.2 Brief description of nature of the Project
Expansion of existing manufacturing and repacking unit by addition of new products and
solvent distillation unit (in-house or common group facility).
2.3 Need for the project and its importance to the country and or region
The Indian pharmaceutical industries currently tops amongst India’s science based
industries with wide ranging capabilities in the complex field of pharmaceutical. The
pharmaceutical industries in India meets around 60% of the country’s demand. But in world
market also Indian pharmaceutical products are well accepted. There is a good potential for
us to fulfill the need of domestic market as well as contribute in earning foreign Exchange.
2.4 Demands-Supply Gap
Based on our informal survey of the market with our current customers and various traders,
we have found that there is a big potential for the range of the products we are planning.
2.5 Imports vs. Indigenous production
Based on the current cost of indigenous raw materials and the non availability of some
materials, we will have to import, if require, some of the key raw materials as they are not
available indigenously. This will make us very competitive against imported finished
products and we will export our finished products in the international market.
2.6 Export possibility
We shall explore the possibility of export the products.
2.7 Domestic/Export Markets
17
Our products have good demand in international market. We shall explore the possibility of
export the products.
2.8 Employment Generation (Direct and Indirect) due to project.
M/s. Suleshvari Pharma will give direct employment, if required, to local people based on
qualification and requirement after proposed expansion. In addition to direct employment,
indirect employment shall generate ancillary business to some extent for the local
population.
3.0
Project Description
3.1 Type of Project including interlinked and interdependent projects, if any.
No interlinked project has been submitted.
3.2 Location (map showing general location, specific location and project boundary &
project site layout) with coordinates.
•
Map showing general location
(Courtesy: Environmental Information Center, New Delhi)
18
•
Specific location and project boundary
19
Plot Layout
20
3.3 Details of alternate sites considered and the basis of selecting the proposed site,
particularly the environmental considerations gone into should be highlighted.
Major factors involved in the selection of site are listed below:
• Existing operational unit
• Site is very well connected by road
• Proximity to Raw Material suppliers
• Availability of sufficient land free from cultivation
• Availability of power evacuation facilities
• Availability of water for industrial use
Modern infrastructure support and amenities at par with industrial estates in other global
markets, including:
Efficient transport facilities within the industrial estate and to & fro the city area.
Environment-friendly zone.
Uninterrupted power supply.
3.4 Size or Magnitude of Operation
Please refer Section-1.2.1, Page No. 2.
3.5 Project Description with process details (a schematic diagram/flow chart showing the
project layout, components of the project, etc. should be given)
Please refer Please refer Form-I, Annexure-3.
3.6 Raw Material required along with estimated quantity, likely source, marketing area of
final product/s, mode of transport of raw material and Finished product.
For raw material required along with quantity; Please refer Section-1.3, Page No. 3. We shall
procure the raw material as much as possible from domestic market and if there is no
availability of any raw material we will import. We shall explore the possibility of export the
finished products.
3.7 Resource optimization/recycling and reuse envisaged in the project, if any, should be
briefly outlined.
Resource optimization/recycling and reuse shall be envisaged
21
3.8 Availability of water its source, energy/power requirement and source should be
given.
Water Source
Total water requirement meets through GIDC water supply and will be the same after
proposed expansion.
Power & Fuel Requirement
Power required from GEB is 100 KVA (Existing)
Power required from GEB will 250 KVA (Proposed)
1 D.G. Set = 150 KVA (Proposed) (during Emergency Only)
Fuel:
Natural Gas = 300 m3/Day (Existing)
Agro Waste/Briquettes = 5 MT/Day (Proposed)
HSD = 20 Liter/Hr (Proposed) (during Emergency Only)
3.9 Quantity of wastes to be generated (liquid and solid) and scheme for their
management/disposal.
Please refer Form-I, Annexure-IV & V.
3.10 Schematic representations of the feasibility drawing which give information of EIA
purpose.
ACTIVITIES
RECONNAISSANCE SURVEY OF EXISTING PLANT
MONITORING OF AIR, WATER & SOIL QUALITY & NOISE
LEVELS. DATA ON METEOROLOGY SOCIO-ECONOMIC STATUS
& BASIC AMENITIES. SITE VISITS BY AND INTERVIEWS WITH
LOCALS
OVERVIEW OF
E. I. A. STUDIES
INTRODUCTION
BASELINE
ENVIRONMENTAL
STATUS
SOCIOECONOMIC
STATUS &
INFRASTRUCTURE
PROPOSED
PLANT
SOURCE OF INFORMATION
ANNUAL REPORT
MARKET ASSESSMENT
FINANCIAL REPORT
PROJECT REPORT
ENVIRONMENTAL INFORMATION CENTRE
CENTRAL GROUND WATER BOARD
GUJARAT POLLUTION CONTROL BOARD (GPCB)
PUBLIC HEALTH ENGINEERING DEPT.
AGRICULTURE DEPARTMENT
FOREST DEPARTMENT
IRRIGATION DEPARTMENT
EMPLOYMENT EXCHANGE
HEALTH CENTER
CENSUS DEPT.
INDIAN METEOROLOGICAL DEPT.
FACILITY DESCRIPTION
IDENTIFICATION & ASSESSMENT OF IMPACTS
EVALUATION OF IMPACTS BY MATRIX METHOD
IMPACTS
METHODOLOGY OF
IMPACT
ASSESSMENT
DESCRIPTION OF EFFLUENT TREATMENT PLAN, AIR
POLLUTION CONTROL, HAZARDOUS WASTE MANAGEMENT,
GREEN BELT DEVELOPMENT MONITORING PROGRAM
ENVIRONMENTAL
MANAGEMENT PLAN
CONSEQUENCE ANALYSIS
PREPARATION OF DISASTER MANAGEMENT PLAN
RISK ANALYSIS
STUDIES &
DISASTER
MANAGEMENT PLAN
SAFETY, HEALTH & ENVIRONMENTAL POLICY, GUIDELINES BY
DIRECTOR GENERAL OF FACTORY SAFETY, MINISTRY OF LABOR.
22
4.0 Site Analysis
4.1 Connectivity
•
Site is very well connected by road
•
Availability of water, power, etc.
4.2 Land Form, Land Use and Land Ownership
It will be incorporated in EIA Report.
4.3 Existing land use pattern (agriculture, non-agriculture, forest, water bodies (including
area under CRZ)), shortest distances from the periphery of the project to periphery of the
forests, national park, wild life sanctuary, eco sensitive areas, water bodies (distance from
HFL of the river), CRZ. In case of the notified industrial area, a copy of the Gazette
notification should be given.
It will be incorporated in EIA Report. CRZ Clearance is not applicable.
4.4 Existing Infrastructure
Processing Area (Plant facilities, R&D, ETP Area and Engineering / Utility Services) = 1200 m2
Non Processing Area (Green belt, Raw material storage area, finished storage area,
Administration Building, Parking, road and open area) = 1,145 m2
4.5 Soil Classification
It will be incorporated in EIA Report.
4.6 Climatic data from secondary sources.
Climatic data from primary & secondary sources will be incorporated in EIA Study.
4.7 Social infrastructure available.
Various Programs/ Projects related to Social & Economic development of surrounded area
has been planned, which are as follows.
A) Natural Resource Management – The main focus of this program will be to maximize the
yield returns of the farmers through efficient management of existing resources &
extension of new agricultural practices.
23
1) Integrated Agricultural Growth Project – For improvement and use of the modern
techniques and thereby would certainly contribute to prosperity in the agriculture
sector and reduce the rural poverty by programs like Farmers Training, Nursery
Growing Trainings, Modern agriculture equipment distribution programs etc.
2) Animal Husbandry Projects – Various programs like health checkups & treatment,
vaccination program, Anti sterility camps, breed improvement etc. will be carried
out.
B) Income Generation Program 1) Establishment of Self help groups.
2) Rural Entrepreneurship Development Program
3) Handcrafts Development Program
4) Vocational Training
5) Business process outsourcing
C) Health, Education & Infrastructure
1) Aids Awareness Program
2) General Health Camps
3) Innovative Teaching Methods
4) Adult Education
5) Sanitation
6) Infrastructure Development Projects
5.0 Planning Brief
5.1 Planning Concept (type of industries, facilities, transportation etc) Town and Country
planning/Development authority classification.
Expansion of existing manufacturing and repacking unit by addition of new products and
solvent distillation unit (in-house or common group facility) within existing premises.
5.2 Population Projection
Population data will be incorporated in EIA Study.
5.3 Land use planning (breakup along with green belt etc.)
24
Industrial Area (Processing Area)
Processing Area (Plant facilities, R&D, ETP Area and Engineering / Utility Services) = 1200 m2
Residential Area (Non Processing Area)
Non Processing Area (Green belt, Raw material storage area, finished storage area,
Administration Building, Parking, road and open area) = 1145 m2
Total 2345 m2 land area is available at site; out of this area about 790 sq. meter (33 %) area
will be covered as greenbelt and other forms of greenery.
5.4 Assessment of Infrastructure Demand (Physical & Social)
•
Employment would be as per prevailing norms of state government for skilled and
unskilled people for the proposed project activity.
•
Social Welfare
•
Cordial relation with the industry shall be established and representation shall be made
to villagers for help for creation of facilities related to health, education, etc.
5.5 Amenities/Facilities
It will be incorporated in EIA Report.
6.0 Proposed Infrastructure
6.1 Industrial Area (Processing Area)
Processing Area (Plant facilities, R&D, ETP Area and Engineering / Utility Services) = 1200 m2
6.2 Residential Area (Non Processing Area)
Non Processing Area (Green belt, Raw material storage area, finished storage area,
Administration Building, Parking, road and open area) = 1145 m2
6.3 Green Belt
Total 2345 m2 land area is available at site; out of this area about 790 sq. meter (33 %) area
will be covered as greenbelt and other forms of greenery.
6.4 Social Infrastructure
25
•
•
Water Supply by GIDC
Power supply by DGVCL
6.5 Connectivity (Traffic and Transportation Road/ Rail/Metro/ Water ways etc)
Major factors involved in the selection of site are listed below:
• Site is very well connected by road
• Proximity to Raw Material suppliers
• Availability of sufficient land free from cultivation
• Availability of power facilities
• Availability of water for industrial use
6.6 Drinking water Management (Source & Supply of water)
Total water requirement shall meet through GIDC supply.
6.7 Sewerage System
Sewage pipes are laid in entire company for the removal and disposal of mainly nonharmful liquid wastes from the offices, canteen and domestic waste coming from different
sections of industry. These liquid wastes are sent to septic tank & soak pit.
6.8 Solid Waste Management
Please refer Form-I, Annexure-V.
6.9 Power Requirement & Supply/Source
Please refer Section 1.8, Page No.6 of this report.
7.0 Rehabilitation and Resettlement (R & R) Plan
7.1 Policy to be adopted (central/state) in respect of the project affected including home
oustees, land oustees and landless laborers (a brief outline to be given)
There is no habitation on the proposed project activity area and it is open industrial land, so
R & R policy is not applicable to this project. There shall not be displacement of any
population in project area. The increasing industrial activity will boost the commercial and
economical status of the locality up to some extent.
8. Project Schedule & Cost Estimates
8.1 Likely date of start of construction and likely date of completion (Time schedule for
the project to be given).
We shall start construction after getting EC & CTE. We shall start manufacturing after
applying for CCA.
26
8.2 Estimated Project cost along with analysis in terms of economic viability of the
project.
Total Project Cost for proposed project activity is Rs. 3 Crores. Capital cost of air & water
pollution control system and environmental monitoring equipments will be Rs. 0.5 Crore.
9. Analysis of Proposal (Final Recommendations)
9.1 Financial and social benefits with special emphasis on the benefit to be local people
including tribal population, if any, in the area.
•
Employment would be as per prevailing norms of state government for skilled and
unskilled people for the proposed project.
•
Social Welfare shall be done.
•
Cordial relation with the industry shall be established and representation shall be made
to villagers for help for creation of facilities related to health, education, etc.
27